These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2671601)
1. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus. Selam JL; Kashyap M; Alberti KG; Lozano J; Hanna M; Turner D; Jeandidier N; Chan E; Charles MA Metabolism; 1989 Sep; 38(9):908-12. PubMed ID: 2671601 [TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients. Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827 [TBL] [Abstract][Full Text] [Related]
3. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
4. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients. Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG Diabetologia; 1985 Oct; 28(10):728-33. PubMed ID: 3905470 [TBL] [Abstract][Full Text] [Related]
5. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity. Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191 [TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy. Viberti GC; Home PD; Bilous RW; Alberti KG; Dalton N; Keen H; Pickup JC Acta Endocrinol (Copenh); 1984 Apr; 105(4):515-20. PubMed ID: 6372348 [TBL] [Abstract][Full Text] [Related]
7. The metabolic response to the euglycemic insulin clamp in type I diabetes and normal humans. Zuniga-Guajardo S; Zinman B Metabolism; 1985 Oct; 34(10):926-30. PubMed ID: 3900631 [TBL] [Abstract][Full Text] [Related]
8. Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusion. Massi Benedetti M; Home PD; Gill GV; Burrin JM; Noy GA; Alberti KG Diabetes Res Clin Pract; 1987; 3(6):307-17. PubMed ID: 3311678 [TBL] [Abstract][Full Text] [Related]
9. The metabolic response to moderate exercise in diabetic man receiving intravenous and subcutaneous insulin. Murray FT; Zinman B; McClean PA; Denoga A; Albisser AM; Leibel BS; Nakhooda AF; Stokes EF; Marliss EB J Clin Endocrinol Metab; 1977 Apr; 44(4):708-20. PubMed ID: 849981 [TBL] [Abstract][Full Text] [Related]
10. Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients. Katz HH; Nguyen TT; Velosa JA; Robertson RP; Rizza RA Mayo Clin Proc; 1994 Mar; 69(3):231-6. PubMed ID: 8133660 [TBL] [Abstract][Full Text] [Related]
11. Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery. Selam JL; Kashyap ML; Gupta AK; Turner D; Wong ND; Lozano JL; Charles MA Metabolism; 1994 Jun; 43(6):665-9. PubMed ID: 8201953 [TBL] [Abstract][Full Text] [Related]
12. Near normalization of metabolism of IDDM: comparison of continuous subcutaneous (CSII) versus intraperitoneal (CIPII) insulin delivery. Gooch BR; Abumrad NN; Robinson RP; Crofford OB Horm Metab Res; 1984 Dec; 16 Suppl 1():190-4. PubMed ID: 6398261 [TBL] [Abstract][Full Text] [Related]
13. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration. Scarpioni L; Ballocchi S; Castelli A; Scarpioni R Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664 [TBL] [Abstract][Full Text] [Related]
14. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise. Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952 [TBL] [Abstract][Full Text] [Related]
15. Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs. Stevenson RW; Orskov H; Parsons JA; Alberti KG Am J Physiol; 1983 Aug; 245(2):E200-8. PubMed ID: 6349384 [TBL] [Abstract][Full Text] [Related]
16. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Scheen A; Castillo M; Jandrain B; Krzentowski G; Henrivaux P; Luyckx AS; Lefèbvre PJ Diabetes Care; 1984; 7(4):338-42. PubMed ID: 6381007 [TBL] [Abstract][Full Text] [Related]
17. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes. Ruotolo G; Micossi P; Galimberti G; Librenti MC; Petrella G; Marcovina S; Pozza G; Howard BV Metabolism; 1990 Jun; 39(6):598-604. PubMed ID: 2191189 [TBL] [Abstract][Full Text] [Related]
18. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717 [TBL] [Abstract][Full Text] [Related]
19. The metabolic and hormonal adaptations of normal dogs to long-term exogenous sulfated insulin infusions. Nomura M; Greenberg GR; Bahoric A; Albisser AM Metabolism; 1986 Oct; 35(10):892-8. PubMed ID: 3531758 [TBL] [Abstract][Full Text] [Related]
20. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Fulcher GR; Walker M; Farrer M; Johnson AS; Alberti KG Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]